Ketamine for Anhedonia: Reigniting the Ability to Feel

If you have ever sat in front of the things you used to love, the music, the meal, the people, and felt almost nothing, you already understand anhedonia better than any textbook can explain it. It is one of the cruelest features of depression precisely because it is so quiet. There is no dramatic crisis to point to. There is just a slow draining of color from a life that, on paper, should feel meaningful.

I am Dr. Ben Soffer, a board-certified physician, and anhedonia is one of the symptoms I take most seriously when I evaluate patients. Not because it looks the most severe from the outside, but because it is so often the part that no previous treatment touched. People come to me having tried medication after medication. The crying may have stopped. The crushing weight may have lifted a little. And yet the flatness remains. This post is about why that happens, what the research suggests about ketamine's distinct effect on anhedonia, and what honest treatment looks like.

What anhedonia actually is, and how it feels

Anhedonia is the reduced ability to feel pleasure or interest. The word comes from Greek roots meaning, literally, the absence of pleasure. Clinically, it is one of the two core symptoms used to diagnose major depression, alongside persistently low mood. But describing it as a "symptom" undersells how total it can feel.

Patients describe it in remarkably consistent ways. Food tastes like cardboard. Their favorite album sounds like noise. A hobby that once absorbed entire weekends now feels like a chore they cannot make themselves start. Sometimes it shows up as a loss of pleasure (consummatory anhedonia), and sometimes as a loss of the motivation and drive to even pursue things in the first place (motivational anhedonia). Often both are present at once.

What surprises people most is that anhedonia is not the same as sadness. Sadness is a feeling. Anhedonia is closer to the absence of feeling. Many of my patients say the numbness is harder to bear than the pain ever was, because at least pain reminds you that you are still in there somewhere. I write more about how this presents on our dedicated anhedonia overview page, and if it resonates, that is worth a read.

It also tends to be a marker of severity and stubbornness. In the clinical literature, anhedonia is closely tied to treatment resistance, suicidality, and poorer outcomes. That is part of why it deserves a treatment conversation of its own, rather than being folded into a general plan to "treat the depression" and hoping it lifts along with everything else.

Why standard antidepressants so often miss it

Here is something that frustrates a lot of patients, and frankly frustrates a lot of clinicians too. The most commonly prescribed antidepressants, the SSRIs and SNRIs, are genuinely helpful for many people. But they frequently leave anhedonia behind.

There are a few reasons for this. The first is mechanistic. These medications act primarily on serotonin (and in some cases norepinephrine) systems, and the framework they grew out of was built largely around mood and anxiety. The brain's reward machinery, the circuitry that drives motivation and the capacity to anticipate and enjoy things, is not the primary target of a typical SSRI. So it is entirely possible for one of these medications to take the edge off the despair while doing little for the flatness underneath.

The second reason is more uncomfortable: some people experience emotional blunting on serotonergic antidepressants. This is a muting of feeling across the board, both the lows and the highs. For someone whose central complaint is already that they cannot feel pleasure, a medication that further flattens emotional range can make the problem feel worse, not better. I have had patients tell me they could not tell whether their lack of joy was the depression or the pill meant to treat it. That is a real and validating thing to name out loud.

This is increasingly recognized in the research. A recent review of current and future treatments for anhedonia makes the case that it is genuinely difficult to treat with standard antidepressants and that it calls for more targeted approaches (Serretti, 2025). In other words, the field itself is acknowledging that the old toolkit was not designed for this particular problem. If you have already been through the SSRI gauntlet without your interest and pleasure returning, you are not imagining the gap, and you are certainly not failing at treatment. The treatment was simply aimed somewhere else. I have written separately about what comes next after antidepressants have not worked, which covers this territory in more depth.

What the research suggests about ketamine and anhedonia

Ketamine is a different kind of medication, and the way it engages the brain is different in a way that matters here. Rather than acting primarily on serotonin, ketamine works through the glutamate system, the brain's main excitatory signaling network, and is thought to promote rapid changes in how neurons connect and adapt. That distinction is part of why researchers have been so interested in whether ketamine reaches symptoms that serotonergic drugs leave behind.

One of the more striking findings is that ketamine appears to have an anti-anhedonic effect that is, at least in part, separable from its general antidepressant effect. In a study of treatment-resistant bipolar depression, researchers documented an anti-anhedonic effect of ketamine along with identifiable neural correlates, meaning the change in anhedonia could be tied to specific patterns of brain activity rather than being a vague byproduct of feeling better overall (Lally et al., 2014). That is an important nuance. It suggests ketamine is not simply lifting mood and dragging anhedonia along for the ride; it may be acting on the reward-related machinery more directly.

More recent work has continued in this direction across both forms of depression. A 2024 synthesis examined ketamine treatment for anhedonia specifically in unipolar and bipolar depression, treating anhedonia as a target in its own right rather than a secondary outcome (Kwasny et al., 2024). The fact that researchers are now studying anhedonia as the endpoint, rather than just total depression scores, reflects a real shift in how seriously the field takes this symptom and ketamine's potential role in addressing it.

It is worth being precise about what these studies do and do not establish. They point toward a distinct anti-anhedonic signal and toward neural correlates that make the effect biologically plausible. They do not prove that ketamine will restore pleasure for any given individual, and the research base, while promising, is still developing. I find the consistency of the direction encouraging, but I hold it honestly. For a fuller picture of ketamine's overall evidence base and how it is used in depression, our guide on ketamine for depression is a good companion to this article.

The proposed reward-circuit mechanism, in plain terms

If you want to understand why anhedonia is so resistant and why ketamine might reach it, the concept worth holding onto is the brain's reward circuitry.

Think of the reward system as the part of the brain that decides what is worth wanting, motivates you to pursue it, and lets you register satisfaction when you get it. It is the engine behind the simple pull toward a good cup of coffee in the morning or the anticipation of seeing a friend. In anhedonia, that engine is running rough. The "worth wanting" signal goes quiet, the pursuit feels pointless, and the satisfaction does not land.

A 2025 piece framed this idea directly, describing how ketamine may reignite the drive for reward, with mechanistic discussion of how it acts on reward circuitry to address anhedonia (McClung, 2025). I like the word "reignite" because it matches what some patients describe: not a manufactured high, but the return of an ordinary capacity that had gone offline. The pull toward a walk outside. A flicker of curiosity. The first time in a long while that a meal actually tastes like something.

The honest scientific caveat is that the precise mechanisms are still being worked out, and the brain's reward system is complex. But the through-line across this work, from the neural correlates of an anti-anhedonic response to the reward-circuit framing, helps explain why a glutamate-acting medication might reach a symptom that serotonin-focused medications often miss. The mechanism is genuinely different, which is exactly why it is worth considering when the usual approaches have not worked.

What at-home sublingual ketamine treatment looks like

At Tovani Health, we provide physician-led, at-home ketamine therapy for patients in Florida and New Jersey, and anhedonia is one of the presentations we treat thoughtfully.

Treatment does not begin with a prescription. It begins with a medical eligibility review and a consultation with a physician. We look at your full history, the medications and treatments you have already tried, your physical health, and your specific symptom pattern, including how much of what you are experiencing is flatness and loss of interest rather than low mood alone. That distinction actually shapes how we think about your plan.

If you are a good candidate, we prescribe sublingual ketamine, meaning a form that dissolves under the tongue, for use at home under our protocol. You do your sessions in your own space, somewhere calm and private, with clear guidance on dosing, setting, and what to expect. We provide monitoring and structured follow-up, and we pay attention to how your symptoms respond over time rather than treating the medication as a one-and-done event. If you want the full walkthrough of how ketamine therapy works from start to finish, our complete medical guide to ketamine therapy lays it all out.

We also track anhedonia as its own outcome where it is part of your picture, because, as the research suggests, it can respond on a somewhat separate track from general mood. Watching that specific thread tells us something useful about whether the treatment is reaching what you actually came in for.

An honest note on limits

I would not be doing my job if I let any of this read like a promise. Here is the part I make sure every patient hears.

Ketamine is not a cure for anhedonia, and it does not work the same way for everyone. Some people experience a meaningful return of interest and pleasure. Others have a partial response, where some color comes back but not all of it. And some people do not respond much at all. The research points toward a real and distinctive anti-anhedonic effect, but a population-level signal is not a personal guarantee, and I will not pretend otherwise.

That is exactly why a responsible plan includes what happens if the response is incomplete. We do not just hand you a medication and hope. We monitor, we reassess, and we adjust, and if ketamine is not getting you where you need to be, we talk honestly about that rather than asking you to keep chasing it. I have written a whole piece on what to do if ketamine therapy does not work, because that conversation deserves real space, not a footnote.

What I can say with confidence is this. If anhedonia has been the part of your depression that nothing seemed to reach, ketamine represents a genuinely different mechanism than the treatments you have likely already tried. That difference is not hype. It is pharmacology. And for a symptom this stubborn, a real difference in approach is worth taking seriously, with eyes open about both its promise and its limits.

See if at-home ketamine therapy is right for you

If the flatness has been the hardest part to shake, you do not have to keep guessing about whether something different could help. The first step is simple and carries no obligation: a quick eligibility check, followed by a conversation with a physician who will look at your full picture honestly.

Check your eligibility →

Or call us at 561-468-6981 if you would rather talk it through with a person first. Either way, you will get a straight answer about whether you are a candidate and what a thoughtful plan would look like.

Benjamin Soffer, DO — Tovani Health

---

Related reading: Anhedonia: what it is and how it feels, Ketamine for depression, Ketamine after failing antidepressants, What to do if ketamine therapy doesn't work